Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

Clinical trial NCT06929806 · RECRUITING

Trial details

NCT number: NCT06929806
Sponsor: Pharmacosmos A/S
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Heart Failure Iron Deficiencies

Start date: 2025-05-01
Primary completion: 2027-12-01
Enrollment: 1900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.